Inhibitors of protein phosphatase-1 and uses thereof
AssigneeHoward University
InventorsSergei Nekhai, Dmytro Borysovich Kovalskyy
Life of this patent
Estimating the term…
Abstract
Inhibitors of Protein Phosphatase-1 have been shown to slow replication of HIV-1. Inhibitors of PP 1 and their use for treatment or prevention of HIV-1 infections are disclosed.
Claims15
A compound of formula (I) comprising:
- wherein n is 1 or 2;
- Ar is phenyl or thienyl, and is optionally substituted;
- each R1 is independently R6, C(O)R6, C(O)—OR6, or C(O)N(R 6)2;
- R2 is H or optionally substituted C1-C6 alkyl, or a group of formula —C(O)NH—R1;
- R3 is independently at each occurrence selected from halo, NO2, CN, R, OR, NR2;
- S(O)qR, COOR, and CONR2, where each R is independently H, C1-C4 alkyl, or C1-C4 haloalkyl;
- m is 0-4;
- R4 is R6, halo, =0, COOR6, CO N(R6)2, S(O)qR6, N(R6)2, or OR6;
- p is 0-2;
- each q is independently 0-2;
- Z is 0 or NR5;
- R5 is R6 or C(O)R6;
- and
- R6 is independently at each occurrence selected from H, C1-C6 alkyl, C5-C6 aryl, and (C5-C6-aryl)-C1-C6 alkyl, where each alkyl and aryl is optionally substituted;
- provided that n is 2 when Z is 0 and Ar represents para-halophenyl;
- or a pharmaceutically acceptable salt thereof.
A pharmaceutical composition comprising a compound of formula (I) admixed with at least one pharmaceutically acceptable excipient or diluent.
A method for treating a subject infected with or at risk of infection with HIV-1, the method comprising administering to a subject in need of such treatment a therapeutically effective amount of a compound of formula (I).
A method to inhibit replication of HIV-1 virus, comprising contacting the HIV-1 virus or a cell containing the HIV-1 virus with a compound of formula (I).
A compound selected from the group consisting of
- and pharmaceutically acceptable salts of these compounds.
A method for treating a subject infected with or at risk of infection with HIV-1, the method comprising administering to a subject in need of such treatment a therapeutically effective amount of a compound selected from the group consisting of Compound A
- and pharmaceutically acceptable salts of these compounds.
A method to inhibit replication of HIV-1 virus, comprising contacting the HIV-1
- virus or a cell containing the HIV-1 virus with a compound selected from the group consisting of Compound A
- and pharmaceutically acceptable salts of these compounds.
Dependencies are inferred from the claim text.